simvastatin has been researched along with Local Neoplasm Recurrence in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahern, TP; Christiansen, PM; Cronin-Fenton, DP; Damkier, P; Ejlertsen, B; Feddersen, S; Hamilton-Dutoit, S; Kjærsgaard, A; Lash, TL; Lythjohan, CB | 1 |
| Chen, L; Chen, Z; Guo, H; Han, Z; He, Y; Li, G; Liu, D; Luo, Y; Qi, L; Sun, B; Zhan, L; Zhang, N; Zhang, S; Zhu, K | 1 |
| Ahern, TP; Christiansen, P; Cronin-Fenton, D; Damkier, P; Ejlertsen, B; Lash, TL; Sørensen, HT | 1 |
| Alekseev, BY; Galatenko, VV; Nikulin, SV; Poloznikov, AA; Schumacher, U; Shkurnikov, MY; Stürken, C; Wicklein, D | 1 |
| Brewer, T; Buchholz, TA; Debeb, BG; Hortobágyi, GN; Lacerda, L; Larson, R; Li, L; Liu, D; Masuda, H; Reddy, JP; Ueno, NT; Woodward, WA; Xu, W | 1 |
| Sundermeyer, M; Veeraputhiran, M | 1 |
| Ahern, TP; Cronin-Fenton, DP; Garne, JP; Lash, TL; Pedersen, L; Silliman, RA; Sørensen, HT; Tarp, M | 1 |
| Rennert, G | 1 |
8 other study(ies) available for simvastatin and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin.
Topics: Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B; Biomarkers, Tumor; Breast; Breast Neoplasms; Case-Control Studies; Cytochrome P-450 CYP3A; Denmark; Female; Follow-Up Studies; Humans; Liver-Specific Organic Anion Transporter 1; Middle Aged; Neoplasm Recurrence, Local; Pharmacogenomic Testing; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Predictive Value of Tests; Risk Assessment; Simvastatin | 2020 |
LDLR inhibition promotes hepatocellular carcinoma proliferation and metastasis by elevating intracellular cholesterol synthesis through the MEK/ERK signaling pathway.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cholesterol; Disease-Free Survival; Down-Regulation; Female; Flavonoids; HEK293 Cells; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipogenesis; Liver; Liver Neoplasms; Male; MAP Kinase Signaling System; Mice; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Receptors, LDL; RNA-Seq; Simvastatin; Warburg Effect, Oncologic; Xenograft Model Antitumor Assays | 2021 |
Concurrent new drug prescriptions and prognosis of early breast cancer: studies using the Danish Breast Cancer Group clinical database.
Topics: Adrenergic beta-Antagonists; Analgesics, Opioid; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Breast Neoplasms; Cardiotonic Agents; Cyclooxygenase 2 Inhibitors; Databases, Factual; Denmark; Digoxin; Disease Progression; Estrogen Antagonists; Female; Glucocorticoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neoplasm Recurrence, Local; Platelet Aggregation Inhibitors; Prognosis; Selective Serotonin Reuptake Inhibitors; Simvastatin; Tamoxifen | 2018 |
Transcriptome Guided Drug Combination Suppresses Proliferation of Breast Cancer Cells.
Topics: Acetyltransferases; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Combinations; Epithelial-Mesenchymal Transition; Fatty Acid Elongases; Female; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor Binding Proteins; Neoplasm Recurrence, Local; Simvastatin; Transcriptome | 2019 |
Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation.
Topics: Adult; Aged; Cell Differentiation; Chi-Square Distribution; Disease Progression; Disease-Free Survival; Female; Humans; Inflammatory Breast Neoplasms; Kaplan-Meier Estimate; Mastectomy; MCF-7 Cells; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Proportional Hazards Models; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Simvastatin; Spheroids, Cellular; Time Factors; Treatment Outcome; Triple Negative Breast Neoplasms; Young Adult | 2014 |
Rhabdomyolysis resulting from pharmacologic interaction between erlotinib and simvastatin.
Topics: Aged; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atenolol; Azetidines; Carcinoma, Non-Small-Cell Lung; Coronary Artery Disease; Drug Interactions; Erlotinib Hydrochloride; Ezetimibe; Female; Humans; Hyperlipidemias; Hypertension; Lung Neoplasms; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Quinazolines; Rhabdomyolysis; Simvastatin; Tomography, X-Ray Computed | 2008 |
Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.
Topics: Adult; Aged; Anticholesteremic Agents; Breast Neoplasms; Denmark; Drug Prescriptions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Linear Models; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Prospective Studies; Registries; Risk Factors; Secondary Prevention; Simvastatin | 2011 |
Bisphosphonates: beyond prevention of bone metastases.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Drug Prescriptions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Neoplasm Recurrence, Local; Neoplasms; Receptors, Estrogen; Secondary Prevention; Simvastatin; Veterans | 2011 |